DRKS00028043已完成不适用
Medical care of patients with polymyalgia rheumatica: evaluation of guideline-based care and treatment using claims data
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 27,079
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 40 Years 至 one（—）
- 性别
- All
入选标准
- •Persons insured with the AOK Baden-Württemberg (regional health insurance fund), incident diagnosis of polymyalgia rheumatica between 2011 and 2020, age =40 years
排除标准
- •Age <40 years; persons, who were not continously insured with the AOK Baden-Württemberg in the two years prior to the incident polymyalgia rheumatica diagnosis.
研究者
相似试验
已完成
3 期
PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phaseNL-OMON22681Sint Maartenskliniek Nijmegen100
进行中（未招募）
不适用
Improved Diagnostics and Monitoring of Polymyalgia RheumaticaAdrenal InsufficiencyPolymyalgia RheumaticaGiant Cell ArteritisNCT04519580Kresten Krarup Keller98
已完成
不适用
Gene expression profiling in patients with polymyalgia rheumatica before and after symptom-abolishing glucocorticoid treatmentMusculoskeletal DiseasesPolymyalgia rheumaticaISRCTN69503018Bispebjerg Hospital20
进行中（未招募）
不适用
Infliximab en pacientes con polimialgia reumática refractaria a corticoides. Ensayo doble ciego controlado con placebo. (Infliximab in patients with rheumatic polymyalgia refractory to corticosteroids. Double blind placebo controlled trial).Polimialgia reumática (Rheumatic polymyalgia).MedDRA version: 8.1Level: PTClassification code 10036099Term: Polymyalgia rheumaticaEUCTR2006-001081-16-ESVictor Martínez Taboada
终止
2 期
A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154Polymyalgia RheumaticaNCT04972968AbbVie181